Alexander A Fitzpatrick - Net Worth and Insider Trading
Alexander A Fitzpatrick Net Worth
The estimated net worth of Alexander A Fitzpatrick is at least $1 Million dollars as of 2024-11-29. Alexander A Fitzpatrick is the Chief Legal Officer of ARS Pharmaceuticals Inc and owns about 89,227 shares of ARS Pharmaceuticals Inc (SPRY) stock worth over $1 Million. Alexander A Fitzpatrick is also the General Counsel and Secretary of Evofem Biosciences Inc and owns about 179 shares of Evofem Biosciences Inc (EVFM) stock worth over $2. Details can be seen in Alexander A Fitzpatrick's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Alexander A Fitzpatrick has not made any transactions after 2023-09-29 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Alexander A Fitzpatrick
Alexander A Fitzpatrick Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Alexander A Fitzpatrick owns 3 companies in total, including Evofem Biosciences Inc (EVFM) , Silverback Therapeutics Inc (SBTX) , and ARS Pharmaceuticals Inc (SPRY) .
Click here to see the complete history of Alexander A Fitzpatrick’s form 4 insider trades.
Insider Ownership Summary of Alexander A Fitzpatrick
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| EVFM | Evofem Biosciences Inc | 2021-12-20 | General Counsel and Secretary |
| SBTX | Silverback Therapeutics Inc | 2022-12-01 | Chief Legal Officer |
| SPRY | ARS Pharmaceuticals Inc | 2023-09-29 | Chief Legal Officer |
Alexander A Fitzpatrick Latest Holdings Summary
Alexander A Fitzpatrick currently owns a total of 2 stocks. Among these stocks, Alexander A Fitzpatrick owns 89,227 shares of ARS Pharmaceuticals Inc (SPRY) as of September 29, 2023, with a value of $1 Million and a weighting of 100%. Alexander A Fitzpatrick also owns 179 shares of Evofem Biosciences Inc (EVFM) as of December 20, 2021, with a value of $2 and a weighting of 0%.
Latest Holdings of Alexander A Fitzpatrick
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SPRY | ARS Pharmaceuticals Inc | 2023-09-29 | 89,227 | 14.53 | 1,296,468 |
| EVFM | Evofem Biosciences Inc | 2021-12-20 | 179 | 0.01 | 2 |
Holding Weightings of Alexander A Fitzpatrick
Alexander A Fitzpatrick Form 4 Trading Tracker
According to the SEC Form 4 filings, Alexander A Fitzpatrick has made a total of 1 transactions in ARS Pharmaceuticals Inc (SPRY) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in ARS Pharmaceuticals Inc is the acquisition of 86,258 shares on September 29, 2023, which cost Alexander A Fitzpatrick around $320,017.
According to the SEC Form 4 filings, Alexander A Fitzpatrick has made a total of 3 transactions in Evofem Biosciences Inc (EVFM) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in Evofem Biosciences Inc is the acquisition of 13 shares on December 20, 2021, which cost Alexander A Fitzpatrick around $9,750.
Insider Trading History of Alexander A Fitzpatrick
- 1
Alexander A Fitzpatrick Trading Performance
GuruFocus tracks the stock performance after each of Alexander A Fitzpatrick's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Alexander A Fitzpatrick is 43.11%. GuruFocus also compares Alexander A Fitzpatrick's trading performance to market benchmark return within the same time period. The performance of stocks bought by Alexander A Fitzpatrick within 3 months outperforms 4 times out of 5 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Alexander A Fitzpatrick's insider trading performs compared to the benchmark.
Performance of Alexander A Fitzpatrick
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 14.57 | | | | | |
| Relative Return to S&P 500(%) | 14.03 | | | | | |
Alexander A Fitzpatrick Ownership Network
Alexander A Fitzpatrick Owned Company Details
What does Evofem Biosciences Inc do?
Who are the key executives at Evofem Biosciences Inc?
Alexander A Fitzpatrick is the General Counsel and Secretary of Evofem Biosciences Inc. Other key executives at Evofem Biosciences Inc include Chief Financial Officer Yan Zhang , director & 10 percent owner Kim P. Kamdar , and Chief Commercial Officer Atkinson Katherine Cocca .
Evofem Biosciences Inc (EVFM) Insider Trades Summary
Over the past 18 months, Alexander A Fitzpatrick made no insider transaction in Evofem Biosciences Inc (EVFM). Other recent insider transactions involving Evofem Biosciences Inc (EVFM) include a net sale of 104 shares made by Yan Zhang , and a net sale of 10 shares made by Kim P. Kamdar .
In summary, during the past 3 months, insiders sold 0 shares of Evofem Biosciences Inc (EVFM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 114 shares of Evofem Biosciences Inc (EVFM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 114 shares.
Evofem Biosciences Inc (EVFM)'s detailed insider trading history can be found in Insider Trading Tracker table.
Evofem Biosciences Inc Insider Transactions
Alexander A Fitzpatrick Mailing Address
Above is the net worth, insider trading, and ownership report for Alexander A Fitzpatrick. You might contact Alexander A Fitzpatrick via mailing address: 9605 Scranton Road, Suite 200, San Diego Ca 92121.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
